← Leaderboards
David D Eveleth
E And B Technologies, Llc
$974,224
Attributed
$974,224
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $369.3K · FY2014–17$500K$375K$250K$125K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$974,224 · 2
By mechanism
R21$707,940 · 1
R43$266,284 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Edward W Maly · United Nations Children'S Fund$264,005,699
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
VisionAnalogOryctolagus CuniculusCellsAcuteDoseMigrationResponseResearch StudyAntigensAffectAnimal ModelBioterrorismBlindnessAdverse EventCorneal InjuryBaseChronic DiseaseChronicAlkylationBedsClinical TrialsCollaborationsCaveolins
Grant awards (6)
Therapy for ocular mustard gas exposure using engineered FGF derivatives$70,000
R21 · FY2017 · EY · contact PI
Therapy for ocular mustard gas exposure using engineered FGF derivatives$303,690
R21 · FY2016 · EY · contact PI
Novel caveolin modulators as therapeutics for uveitis$22,399
R43 · FY2016 · EY · contact PI
Therapy for ocular mustard gas exposure using engineered FGF derivatives$334,250
R21 · FY2015 · EY · contact PI
Novel caveolin modulators as therapeutics for uveitis$35,000
R43 · FY2015 · EY · contact PI
Novel caveolin modulators as therapeutics for uveitis$208,885
R43 · FY2014 · EY · contact PI